You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-10-03
Court	District Court, D. Delaware	Date Terminated	2016-05-18
Cause	35:271 Patent Infringement	Assigned To	Sue Lewis Robinson
Jury Demand	Plaintiff	Referred To
Patents	7,964,647; 7,964,648; 7,981,938; 8,097,655; 8,415,395; 8,440,722
Link to Docket	External link to docket

Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2018-12-11	415		Gout Flare Patents"). (D.I. 133 ,r 30); U.S. Patent No. 7,964,647 cl. 1; U.S. Patent No. 7,981,…different sets of patents: the Drug-Drug Interaction patents 1 and the Acute Gout Flare Patents. (D.I. 133 …Drug-Drug Interaction patents. (D.I. 376). Thus, only the Acute Gout Flare Patents remain at issue for…both the non-patented method of treating gout prophylaxis with colchicine and the patented method of treating…constitute patent infringement." 843 F.3d at 1332. However, in Power Integrations, the patent at issue	External link to document
2018-12-11	418		later. U.S. Patent No. 7,964,647 cl. 1; U.S. Patent No. 7,981,938 cl. 1. The second set of patents ("…States Patent Nos. 7,964,647 ("the '647 Patent"), 7,964,648 ("the '648 Patent"…medication. U.S. Patent No. 7,964,648 abstract; U.S. Patent No. 8,097,655 abstract; U.S. Patent No. 8,440,722…owns two sets of patents claiming methods of administering colchicine. One set of patents ·("the Acute… infringement of both the DDI Patents and the Acute Gout Flare Patents based upon Mitigare's label	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.